- Home
- MYPS vs AVIR Comparison
MYPS vs AVIR Comparison
Compare MYPS & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYPS
- AVIR
- Stock Information
- Founded
- MYPS 2011
- AVIR 2012
- Country
- MYPS United States
- AVIR United States
- Employees
- MYPS N/A
- AVIR N/A
- Industry
- MYPS EDP Services
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- MYPS Technology
- AVIR Health Care
- Exchange
- MYPS Nasdaq
- AVIR Nasdaq
- Market Cap
- MYPS 229.4M
- AVIR 247.5M
- IPO Year
- MYPS N/A
- AVIR 2020
- Fundamental
- Price
- MYPS $1.99
- AVIR $3.29
- Analyst Decision
- MYPS Hold
- AVIR Hold
- Analyst Count
- MYPS 5
- AVIR 1
- Target Price
- MYPS $3.17
- AVIR $6.88
- AVG Volume (30 Days)
- MYPS 282.7K
- AVIR 491.5K
- Earning Date
- MYPS 11-04-2024
- AVIR 11-07-2024
- Dividend Yield
- MYPS N/A
- AVIR N/A
- EPS Growth
- MYPS N/A
- AVIR N/A
- EPS
- MYPS N/A
- AVIR N/A
- Revenue
- MYPS $298,759,000.00
- AVIR N/A
- Revenue This Year
- MYPS N/A
- AVIR N/A
- Revenue Next Year
- MYPS N/A
- AVIR N/A
- P/E Ratio
- MYPS N/A
- AVIR N/A
- Revenue Growth
- MYPS N/A
- AVIR N/A
- 52 Week Low
- MYPS $1.20
- AVIR $2.75
- 52 Week High
- MYPS $3.04
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- MYPS 51.73
- AVIR 49.07
- Support Level
- MYPS $2.06
- AVIR $3.10
- Resistance Level
- MYPS $2.29
- AVIR $3.27
- Average True Range (ATR)
- MYPS 0.11
- AVIR 0.16
- MACD
- MYPS -0.03
- AVIR 0.02
- Stochastic Oscillator
- MYPS 41.38
- AVIR 55.28
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore, and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).